Bradley Melville, MD
Physical Medicine & Rehabilitation · Ogden, UTNPI 1407867658
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $488 of the $557 with a category attached, or 87.6%. 11 manufacturers reported payments, led by Merz Pharmaceuticals, LLC at 30.4% of the total. Reporting peaked in 2022 at $228 and has fallen 78.0% since, to $50 in 2025.
Across 25 payments — averaging $22.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz Pharmaceuticals, LLC$169
- Nevro Corp.$86
- Radius Health, Inc.$82
- Saol Therapeutics Inc.$62
- Pfizer$43
- Medtronic$26
- plus $89 from 5 others
What the payments were for
- Food & beverage$48888%
- Education$397%
- Gifts$305%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz Pharmaceuticals, LLC | 6 | $169 |
| Nevro Corp. | 4 | $86 |
| Radius Health, Inc. | 3 | $82 |
| Saol Therapeutics Inc. | 2 | $62 |
| Pfizer | 3 | $43 |
| Medtronic | 2 | $26 |
| Averitas Pharma Inc. | 1 | $25 |
| Boston Scientific | 1 | $19 |
| Arteriocyte Medical Systems, Inc. | 1 | $18 |
| Relievant Medsystems, Inc. | 1 | $16 |
| SPR Therapeutics, Inc | 1 | $11 |
How this compares
$557 in reported general payments places this provider in the 60th percentile of 117 physical medicine & rehabilitation providers in Utah.
See all physical medicine & rehabilitation providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $588 |
| Baclofen | 26 | $556 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $391 |
| Gabapentin | 17 | $151 |
| Naproxen | 17 | $100 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Ogden
- Michael WrightOgden$444
- Scott AdelmanPark City$143K
- Judith GoochSlc$43K
- Colby BealSt George$25K
- Stephen AndersonBountiful$11K
- Timothy GrangeSalt Lake City$11K
- Matthew IrvinSt George$9K
- Steven EdgleySalt Lake City$8K
- Ammon HillsLogan$8K
- Taylor BurnhamSalt Lake City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.